Healing & Recovery Research Peptides Guide
Overview
This guide covers 6 research peptides in the Healing & Recovery category. Each compound is evaluated on its evidence base, mechanism, safety profile, and current clinical status.
BPC-157 — Phase I–II Clinical Trials
Evidence: C | Status: Research-only / No approved human indication. Phase I oral safety trial completed; Phase II UC trial underway.
BPC-157 is a synthetic 15-amino-acid peptide (sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, MW ~1419.5 g/mol) derived from a protein found in human gastric juice.
Use cases: Injury Recovery, Gut Health
TB-500 — Preclinical
Evidence: D | Status: Research-only / Veterinary use in some jurisdictions. Limited human RCTs completed.
TB-500 is a synthetic fragment of thymosin beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide found throughout human tissues.
Use cases: Injury Recovery, Anti-Inflammatory
Thymosin Beta-4 — Phase III / NDA Filed
Evidence: B | Status: Multiple Phase II and Phase III clinical trials for ophthalmic indications. No full FDA approval yet.
Thymosin beta-4 (Tβ4) is a naturally occurring 43-amino acid protein found in virtually all human and animal cells. It is the most abundant member of the beta-thymosin family and plays fundamental roles in cell migration, wound healing, and tissue...
Use cases: Wound Healing, Ophthalmic Research
Larazotide — Phase III / NDA Filed
Evidence: B | Status: Phase III completed (INN-202/CeDLara trial). Awaiting further development steps.
Larazotide (AT-1001) is a synthetic 8-amino acid peptide that acts as a tight junction regulator. It is being developed as an oral adjunct therapy for celiac disease, designed to reduce intestinal permeability ("leaky gut") triggered by gluten...
Use cases: Celiac Disease, Gut Health
Collagen Peptides — No Regulatory Activity
Evidence: F | Status: Dietary supplement with multiple published RCTs. Not a pharmaceutical product.
Collagen peptides (hydrolyzed collagen) are a mixture of small peptides (typically 2-5 kDa) produced by enzymatic hydrolysis of collagen from animal sources (bovine, porcine, marine).
Use cases: Skin Health, Joint Health, Bone Health
BPC-157 + TB-500 — Limited Evidence
Evidence: D | Status: Preclinical
A popular combination blend of two leading tissue repair peptides, BPC-157 and TB-500, often used together in research for synergistic healing effects.
Use cases: Enhanced tissue repair, Synergistic healing, Recovery support
Related Products
Related Research News
TB-500: Thymosin Beta-4's Role in Healing and Repair
TB-500, known as thymosin β4, is a 43-amino-acid peptide first isolated from calf thymus in 1966 by Goldstein et al. It regulates actin in the body, supporting processes like wound healing, angiogenesis, and inflammation control. Research highlights its potential in treating conditions such as myocardial infarction, corneal injuries, and lung damage.
BPC-157 Gut Health: Gastric Cytoprotection Studies
Research on BPC-157 began with gastric cytoprotection in the early 1990s, led by Sikiric and colleagues at the University of Zagreb. Studies show it protects against ethanol-induced lesions and NSAID damage in rat models, with effects linked to angiogenesis, prostaglandins, nitric oxide, and gut-brain signaling. This body of work highlights its stability for oral use and broad preclinical applications in GI models.
BPC-157 Shelf Life: Lyophilized vs Reconstituted Stability Guide
BPC-157 has a finite shelf life that varies by form and storage. Lyophilized powder lasts 12-18 months refrigerated or 24+ months frozen, while reconstituted solution holds for about 28 days under refrigeration. Factors like temperature, light, and handling influence stability, and researchers should watch for signs of degradation to ensure reliable results.